SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-018959
Filing Date
2023-06-30
Accepted
2023-06-30 07:00:50
Documents
13
Period of Report
2023-06-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20230629_8k.htm   iXBRL 8-K 26266
  Complete submission text file 0001437749-23-018959.txt   172574

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcda-20230630.xsd EX-101.SCH 3849
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20230630_def.xml EX-101.DEF 13380
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20230630_lab.xml EX-101.LAB 17544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20230630_pre.xml EX-101.PRE 13357
7 EXTRACTED XBRL INSTANCE DOCUMENT bcda20230629_8k_htm.xml XML 4245
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 231059391
SIC: 2836 Biological Products, (No Diagnostic Substances)